One-Pot Synthesis of 2-Oxazolines from Ethyl a-Cyanocinnamate Derivatives with
N-Bromoacetamide
May 2014
801
7.57
mp: 86–88ꢀC. 1H NMR (300 MHz, CDCl3)
d
132.6, 129.6 (2), 127.0 (2), 113.1, 82.1, 79.6, 64.2, 21.3, 14.0, 13.5;
HRMS-ESI (m/z): Calcd for C15H16NaN2O3 [M + Na]+ 295.1053,
found: 295.1054.
(d, J = 8.2 Hz, 2H, Ar-H), 7.17 (d, J = 8.1 Hz, 2H, Ar-H), 5.49
(s, 1H, ArCH), 4.45 (q, 2H, CH2CH3), 2.25 (s, 3H, CH3),
1.42 (t, J = 7.1Hz,3H, CH2CH3); 13C NMR (75.5 MHz,
CDCl3) d 164.7, 164.5, 134.6, 132.1 (2), 128.8 (2), 123.6,
112.9, 81.9, 79.0, 64.5, 14.0, 13.6; HRMS-ESI (m/z): Calcd
for C14H13BrNaN2O3 [M + Na]+ 359.0001, found:359.0000.
5-Cyano-5-ethoxyformacyl-2-methyl-4-(4-nitrophenyl)-4,5-
dihydrooxazole (3j). Following general experimental procedure,
the white solid (481mg, 79% yield) was obtained. mp: 99–101ꢀC.
1H NMR(300 MHz, CDCl3) d 8.31 (d, J = 8.5Hz, 2H, Ar-H), 7.52
(d, J = 8.4Hz, 2H, Ar-H), 5.65 (s, 1H, ArCH), 4.49 (q, 2H,
CH2CH3), 2.29 (s, 3H, CH3), 1.45 (t, J = 7.1Hz, 3H, CH2CH3);
13C NMR (75.5 MHz, CDCl3) d 165.1, 164.3, 148.5, 142.5,
129.5, 128.3 (2), 124.1, 112.7, 81.7, 78.6, 64.8, 14.0, 13.6;
HRMS-ESI (m/z): Calcd for C14H13NaN3O5 [M + Na]+ 326.0747,
found: 326.0751.
5-Cyano-5-ethoxyformacyl-2-methyl-4-(4-methoxyphenyl)-4,
5-di-hydrooxazol (3c). Following general experimental procedure,
the colorless oil (564 mg, 98% yield) was obtained. 1H NMR
(300 MHz, CDCl3) d 7.20 (d, J = 8.4 Hz, 2H, Ar-H), 6.94
(d, J = 8.5 Hz, 2H, Ar-H), 5.47 (s, 1H, ArCH), 4.44 (q, 2H,
CH2CH3), 3.82 (s, 3H, OCH3), 2.25 (s, 3H, CH3), 1.41
(t, J = 7.1 Hz, 3H, CH2CH3); 13C NMR(75.5 MHz, CDCl3) d
165.0, 163.8, 160.3, 128.4 (2), 127.6, 114.3 (2), 113.2, 82.2, 79.4,
64.2, 55.2, 14.0, 13.5; HRMS-ESI (m/z): Calcd for
C15H16NaN2O4 [M + Na]+ 311.1002, found 311.1002.
5-Cyano-5-ethoxyformacyl-2-methyl-4-(3-methoxyphenyl)-4,
5-dihydrooxazole (3d). Following general experimental procedure,
the colorless oil (553 mg, 96%yield) was obtained. 1H NMR
(300 MHz, CDCl3) d 7.37–7.32 (m, 1H, Ar-H), 6.94–6.82
(m, 3H, Ar-H), 5.50 (s, 1H, ArCH), 4.44 (q, 2H, CH2CH3),
3.82 (s, 3H, -OCH3), 2.25 (s, 3H, CH3), 1.41(t, J = 6.9 Hz, 3H,
CH2CH3); 13C NMR (75.5 MHz, CDCl3) d 164.9, 164.1,
159.9, 137.1, 130.0, 119.4 (2), 114.6, 113.0, 82.0, 79.5, 64.3,
55.3, 14.0, 13.5; HRMS-ESI (m/z): Calcd for C15H16NaN2O4
[M + Na]+ 311.1002, found: 311.1006.
5-Cyano-5-ethoxyformacyl-4-(furan-2-yl)-2-methyl-4,5-dihy
drooxazole(3k).
Following general experimental procedure,
the white solid (461mg, 93% yield) was obtained. mp: 65–67ꢀC.
1H NMR (300 MHz, CDCl3) d 7.50 (s, 1H, furyl-H), 6.44
(d, J = 6.30 Hz, 2H, furyl-H), 5.57 (s, 1H, furylCH), 4.42
(q, 2H, CH2CH3), 2.22 (s, 3H, CH3), 1.40 (t, J = 7.0 Hz, 3H,
CH2CH3); 13C NMR (75.5 MHz, CDCl3) d 164.8, 164.4,
148.0, 144.0, 112.8, 110.8, 109.9, 80.0, 74.1, 64.4, 13.9,
13.5; HRMS-ESI (m/z): Calcd for C12H12NaN2O4 [M + Na]+
271.0689, found: 271.0692.
5-Cyano-5-ethoxyformacyl-2-methyl-4-(3,4,5-trimethoxyphenyl)-
4,5-dihydrooxazole (3e).
Following general experimental
1
procedure, the colorless oil (627 mg, 90% yield) was obtained. H
NMR (300 MHz, CDCl3) d 6.50 (s, 2H, Ar-H), 5.47 (s, 1H, ArCH),
4.45 (q, 2H, CH2CH3), 3.88 (s, 9H, OCH3), 2.26 (s, 3H, CH3), 1.43
(t, J=7.1Hz, 3H, CH2CH3); 13C NMR(75.5 MHz, CDCl3) d 164.8,
163.9, 153.4 (2), 138.7, 131.0, 113.1, 104.3 (2), 82.1, 79.6, 64.3,
60.7, 56.1 (2), 13.9, 13.5; HRMS-ESI (m/z): Calcd for
C17H20NaN2O6 [M + Na]+ 371.1214, found: 371.1218.
5-Cyano-5-ethoxyformacyl-2-methyl-4-(naphthalen-1-yl)-
4,5-dihydrooxazole (3l).
Following general experimental
procedure, the white crystal (552 mg, 90% yield) was obtained.
mp: 112–114ꢀC. 1H NMR (300MHz, CDCl3) d 7.92–7.52
(m, 7H, Naphthyl-H), 6.43 (s, 1H, NaphthylCH), 4.47 (q, 2H,
CH2CH3), 2.32 (s, 3H, CH3), 1.42 (t, J = 7.1 Hz,3H, CH2CH3);
13C NMR(75.5 MHz, CDCl3) d 165.3, 164.2, 133.9, 130.8, 130.0,
129.4, 126.7, 126.0 (2), 125.6, 125.5, 122.1, 112.9, 82.3, 75.6,
64.5, 13.9, 13.6; HRMS-ESI (m/z): Calcd for C18H16NaN2O3
[M+ Na]+ 331.1053, found: 331.1056.
5-Cyano-5-ethoxyformacyl-4-(3,5-dimethoxyphenyl)-2-methyl-4,
5-dihydrooxazole (3f). Following general experimental procedure, the
1
white solid (540 mg, 88% yield) was obtained. mp: 60–62ꢀC. H
NMR (300 MHz, CDCl3) d 6.47(s, 1H, Ar-H), 6.41 (s, 2H, Ar-H),
5.45 (s, 1H, ArCH), 4.44 (q, 2H, CH2CH3), 3.80 (s, 6H, OCH3),
2.24 (s, 3H, CH3), 1.42 (t, J=7.1Hz, 3H, CH2CH3); 13C NMR
(75.5 MHz, CDCl3) d 164.9, 164.1, 161.1, 137.7, 113.0, 105.3 (2),
100.9 (2), 82.0, 79.5, 64.3, 55.3 (2), 13.9, 13.5; HRMS-ESI (m/z):
Calcd for C16H18NaN2O5 [M + Na]+ 341.1108, found: 341.1113.
5-Cyano-5-ethoxyformacyl-4-(4-fluorophenyl)-2-methyl-4,
5-dihydrooxazole (3g). Following general experimental
procedure, the white solid (469 mg, 85% yield) was obtained.
mp:58.6–61ꢀC. 1H NMR (300MHz, CDCl3) d 7.30–7.09 (m, 4H,
Ar-H), 5.51 (s, 1H, ArCH), 4.45 (q, 2H, CH2CH3), 2.25 (s, 3H,
CH3), 1.42 (t, J = 7.1Hz, 3H, CH2CH3); 13C NMR(75.5 MHz,
CDCl3) d 164.9, 164.2, 161.6, 131.5, 129.0 (2), 116.5, 116.1,
113.0, 82.0, 79.0, 64.4, 13.9, 13.5; HRMS-ESI (m/z): Calcd for
C14H13FNaN2O3 [M + Na]+ 299.0802, found: 299.0804.
4-(4-Chlorophenyl)-5-cyano-5-ethoxyformacyl-2-methyl-4,5-
dihydrooxazole (3h). Following general experimental procedure,
the white solid (479 mg, 82% yield) was obtained. mp: 78–80ꢀC.
1H NMR (300 MHz, CDCl3) d 7.42–7.22 (m, 4H, Ar-H), 5.51
(s, 1H, ArCH), 4.46(q, 2H, CH2CH3), 2.26 (s, 3H, CH3), 1.42
(t, J = 7.0 Hz, 3H, CH2CH3); 13C NMR(75.5 MHz, CDCl3) d
164.7, 164.4, 135.3, 134.2, 129.1 (2), 128.5 (2), 112.9, 81.9,
79.0, 64.3, 14.0, 13.5; HRMS-ESI (m/z): Calcd for
C14H13ClNaN2O3[M + Na]+ 315.0507, found: 315.0523.
(Æ)-5-Cyano-5-ethoxyformacyl-2-methyl-4-styryl-4, 5-
dihydrooxazole (3m).
Following general experimental
1
procedure, the yellow oil (408 mg, 72% yield) was obtained. H
NMR (300 MHz, CDCl3) d7.46–7.31 (m, 5H, Ar-H), 6.77
(d, J = 15.69 Hz, 1H, ArCH), 6.30–6.22 (m, 1H, CH), 5.04 (d, J
=7.2 Hz, 1H, CHCH), 4.41 (q, 2H, CH2CH3), 2.17 (s, 3H,
CH3), 1.38 (t, J = 7.1 Hz, 3H, CH2CH3); 13C NMR(75.5 MHz,
CDCl3) d 164.6, 163.6, 135.6, 128.6 (3), 126.8 (2), 123.3,
121.3, 113.3, 80.8, 77.6, 64.3, 13.9, 13.5; HRMS-ESI (m/z):
Calcd for C16H16NaN2O3 [M + Na]+ 307.1053, found 307.1053.
Acknowledgments. The authors are grateful to the Natural Science
Foundation of Shaanxi Province (2009JM2011) and the Innovation
Foundation of Postgraduate Cultivation of Shaanxi Normal
University (2008CXB009).
REFERENCES AND NOTES
[1] a) Braga, A. L.; Galetto, F. Z.; Taube, P. S.; Paixão, M. W.;
Silveira, C. C.; Singh, D.; Vargas, F. J Organomet Chem 2008, 693, 3563;
b) Lee, S.-H.; Bok, J.; Qi, X.; Kim, S. K.; Leed, Y.-S.; Yoon, J. Tetrahedron
Lett 2007, 48, 7309; c) Yang, D.; Yip, Y. C.; Wang, X. C. Tetrahedron Lett
1997, 38, 7083; d) Reddy, L. R.; Saravanan, P.; Corey, E. J. J Am Chem
Soc 2004, 126, 6230.
4-(4-Bromophenyl)-5-cyano-5-ethoxyformacyl-2-methyl-4,
5-dihydrooxazole (3i).
Following general experimental
procedure, the white solid (551 mg, 82% yield) was obtained.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet